Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...

By comparing people who had these special genes to those who didn’t, the team found that even a small drop in ...

A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.

With over 7 million people over 65 dealing with the degenerative disease — and the number expected to almost double by 2050 — ...

A new study identifies certain neurotoxins responsible for brain inflammation common to early on-set Alzheimer's disease and ...

Data included more than a million participants to find that Alzheimer's risk was up to 76% lower in these cases.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

A new drug targets Alzheimer’s at its earliest, most silent stage — before memory loss ever begins. Credit: Shutterstock. A ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

One in nine over-70s would benefit from drugs to slow Alzheimer’s, according to a study revealing the disease is more common ...

People with genetic variants linked to lower cholesterol levels are less likely to develop dementia, reported a new study published in Alzheimer's & Dementia. The results suggest that maintaining low ...

Prescriptions for the nerve-pain drug have doubled in 15 years as doctors moved away from opioids and benzodiazepines.• ...